pSUPER ERbeta shRNA Citations (2)

Originally described in: Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells.
Zhang G, Liu X, Farkas AM, Parwani AV, Lathrop KL, Lenzner D, Land SR, Srinivas H Mol Endocrinol. 2009 Feb;23(2):146-56. Epub 2008 Dec 23. PubMed Journal

---

Articles Citing pSUPER ERbeta shRNA

Articles
Preferential estrogen receptor beta ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy. Ruddy SC, Lau R, Cabrita MA, McGregor C, McKay BC, Murphy LC, Wright JS, Durst T, Pratt MA. Mol Cancer Ther. 2014 Jul;13(7):1882-93. doi: 10.1158/1535-7163.MCT-13-1066. Epub 2014 Apr 30. PubMed
MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1alpha. Xu H, Zhao L, Fang Q, Sun J, Zhang S, Zhan C, Liu S, Zhang Y. PLoS One. 2014 Dec 22;9(12):e115565. doi: 10.1371/journal.pone.0115565. eCollection 2014. PubMed

If you have published an article using this material, please email us at to have your article added to this page.